BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tomusange K, Wijesundara D, Gummow J, Wesselingh S, Suhrbier A, Gowans EJ, Grubor-Bauk B. Mucosal vaccination with a live recombinant rhinovirus followed by intradermal DNA administration elicits potent and protective HIV-specific immune responses. Sci Rep 2016;6:36658. [PMID: 27853256 DOI: 10.1038/srep36658] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Kasman LM. Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine. Front Immunol 2022;13:871463. [DOI: 10.3389/fimmu.2022.871463] [Reference Citation Analysis]
2 Frenkel LM, Kuller L, Beck IA, Tsai CC, Joy JP, Mulvania TM, Hu SL, Montefiori DC, Anderson DM. Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge. PLoS One 2021;16:e0240495. [PMID: 33914754 DOI: 10.1371/journal.pone.0240495] [Reference Citation Analysis]
3 Frenkel L, Kuller L, Beck I, Tsai C, Joy J, Mulvania T, Montefiori D, Anderson D. Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis reduces risk of subsequent viral challenge.. [DOI: 10.1101/2020.09.30.320820] [Reference Citation Analysis]
4 Pacifici N, Bolandparvaz A, Lewis JS. Stimuli-Responsive Biomaterials for Vaccines and Immunotherapeutic Applications. Adv Ther (Weinh) 2020;:2000129. [PMID: 32838028 DOI: 10.1002/adtp.202000129] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
5 Hsueh FC, Chang YC, Kao CF, Hsu CW, Chang HW. Intramuscular Immunization with Chemokine-Adjuvanted Inactive Porcine Epidemic Diarrhea Virus Induces Substantial Protection in Pigs. Vaccines (Basel) 2020;8:E102. [PMID: 32102459 DOI: 10.3390/vaccines8010102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dong B, Borjabad A, Kelschenbach J, Chao W, Volsky DJ, Potash MJ. Prevention and treatment of HIV infection and cognitive disease in mice by innate immune responses. Brain Behav Immun Health 2020;3:100054. [PMID: 32699842 DOI: 10.1016/j.bbih.2020.100054] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Grubor-Bauk B, Wijesundara DK, Masavuli M, Abbink P, Peterson RL, Prow NA, Larocca RA, Mekonnen ZA, Shrestha A, Eyre NS, Beard MR, Gummow J, Carr J, Robertson SA, Hayball JD, Barouch DH, Gowans EJ. NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice. Sci Adv 2019;5:eaax2388. [PMID: 31844662 DOI: 10.1126/sciadv.aax2388] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
8 Roy S, Jaeson MI, Li Z, Mahboob S, Jackson RJ, Grubor-Bauk B, Wijesundara DK, Gowans EJ, Ranasinghe C. Viral vector and route of administration determine the ILC and DC profiles responsible for downstream vaccine-specific immune outcomes. Vaccine 2019;37:1266-76. [PMID: 30733092 DOI: 10.1016/j.vaccine.2019.01.045] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
9 Huang J, Shen H, Jia R, Wang M, Chen S, Zhu D, Liu M, Zhao X, Yang Q, Wu Y, Liu Y, Zhang L, Yin Z, Jing B, Cheng A. Oral Vaccination with a DNA Vaccine Encoding Capsid Protein of Duck Tembusu Virus Induces Protection Immunity. Viruses 2018;10:E180. [PMID: 29642401 DOI: 10.3390/v10040180] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
10 Wijesundara DK, Ranasinghe C, Grubor-Bauk B, Gowans EJ. Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1. Front Microbiol 2017;8:2091. [PMID: 29118747 DOI: 10.3389/fmicb.2017.02091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]